Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial
Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, de Vita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F, Williamson JD, Carr JJ, Guermazi A, Loeser RF
JAMA 2013 Sep 25;310(12):1263-1273
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

IMPORTANCE: Knee osteoarthritis (OA), a common cause of chronic pain and disability, has biomechanical and inflammatory origins and is exacerbated by obesity. OBJECTIVE: To determine whether a >= 10% reduction in body weight induced by diet, with or without exercise, would improve mechanistic and clinical outcomes more than exercise alone. DESIGN, SETTING, AND PARTICIPANTS: Single-blind, 18-month, randomized clinical trial at Wake Forest University between July 2006 and April 2011. The diet and exercise interventions were center-based with options for the exercise groups to transition to a home-based program. Participants were 454 overweight and obese older community-dwelling adults (age >= 55 years with body mass index of 27 to 41) with pain and radiographic knee OA. INTERVENTIONS: Intensive diet-induced weight loss plus exercise, intensive diet-induced weight loss, or exercise. MAIN OUTCOMES AND MEASURES: Mechanistic primary outcomes: knee joint compressive force and plasma IL-6 levels; secondary clinical outcomes: self-reported pain (range 0 to 20), function (range 0 to 68), mobility, and health-related quality of life (range 0 to 100). RESULTS: Three hundred ninety-nine participants (88%) completed the study. Compared with exercise participants, knee compressive forces were lower in diet participants and IL-6 levels were lower in diet and diet+exercise participants. Mean weight loss for diet+exercise participants was 10.6 kg (11.4%); for the diet group 8.9 kg (9.5%); and for the exercise group 1.8 kg (2.0%). After 18 months, knee compressive forces were lower in diet participants (mean 2,487 N; 95% CI 2,393 to 2,581) compared with exercise participants (2,687 N; 95% CI 2,590 to 2,784, pairwise difference (delta) exercise versus diet = 200 N; 95% CI 55 to 345; p = 0.007). Concentrations of IL-6 were lower in diet+exercise (2.7 pg/mL; 95% CI 2.5 to 3.0) and diet participants (2.7 pg/mL; 95% CI 2.4 to 3.0) compared with exercise participants (3.1 pg/mL; 95% CI 2.9 to 3.4; delta exercise versus diet+exercise = 0.39 pg/mL; 95% CI -0.03 to 0.81; p = 0.007; delta exercise versus diet = 0.43 pg/mL; 95% CI 0.01 to 0.85, p = 0.006). The diet+exercise group had less pain (3.6; 95% CI 3.2 to 4.1) and better function (14.1; 95% CI 12.6 to 15.6) than both the diet group (4.8; 95% CI 4.3 to 5.2) and exercise group (4.7; 95% CI 4.2 to 5.1, delta exercise versus diet+exercise = 1.02; 95% CI 0.33 to 1.71; p (pain) = 0.004; 18.4; 95% CI 16.9 to 19.9; delta exercise versus diet+exercise), 4.29; 95% CI 2.07 to 6.50; p (function) < 0.001). The diet+exercise group (44.7; 95% CI 43.4 to 46.0) also had better physical health-related quality of life scores than the exercise group (41.9; 95% CI 40.5 to 43.2; delta exercise versus diet+exercise = -2.81; 95% CI -4.76 to -0.86; p = 0.005). CONCLUSIONS AND RELEVANCE: Among overweight and obese adults with knee OA, after 18 months, participants in the diet+exercise and diet groups had more weight loss and greater reductions in IL-6 levels than those in the exercise group; those in the diet group had greater reductions in knee compressive force than those in the exercise group. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT00381290.

Full text (sometimes free) may be available at these link(s):      help